Ustekinumab (anti-IL-12/IL-23)

815610-63-0

CNTO 1275

C00024-1mg

Interleukins

Immunology & Inflammation

Ustekinumab (CNTO 1275) is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody used to treat psoriasis. MW=145.6 kDa.

Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles